Project Grant HT94252310481
Award Date 7/1/23
Completion Date 6/30/26
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Edison, NJ, USA
Similar Awards
- Federal Grant Award Summary HMH Hospitals Corporation, operating as Hackensack University Medical Center, received a $4.36 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on September 30, 2025. The grant funds a four-year clinical trial (through September 29, 2029) to evaluate the efficacy of building emotional self-awareness teletherapy at improving psychological health outcomes in service members...
- This Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $708,399.00 to HMH Hospitals Corporation, doing business as Hackensack University Medical Center, to investigate the therapeutic implications of TN BC-specific ETV6 rearrangements, particularly related to chemoresistance and immune evasion. The award began on March 1, 2024 and is scheduled to be completed by February 28, 2027. Hackensack University Medical...
- The U.S. Defense Health Agency has awarded a $1,602,424.00 Project Grant to The Mclean Hospital Corporation Research Management Division, doing business as Mclean Hospital, for the project "APOE AND LIPID MECHANISMS RELEVANT TO COGNITIVE DYSFUNCTION IN PARKINSON'S DISEASE". The award, which runs from Sep 1, 2023 to Aug 31, 2027, is funded through the Military Medical Research and Development program (CFDA 12.420). The goal of this research is to investigate medical solutions for the...
- The U.S. Department of Defense's Defense Health Agency has awarded a $1,400,000 Project Grant to The Methodist Hospital Research Institute (HMRI) in Houston, Texas under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 15, 2024 through September 14, 2027, will support the "Development of a Novel Therapeutic to Treat DNA Damage Associated with Atypical Burns". This project will focus on advanced biomedical...
- Memorial Hermann Health System was awarded a $672,634 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2023 through August 2026 to understand interpersonal violence against individuals with spinal cord injuries and examine related psychosocial impacts. As a large non-profit health system and hospital, Memorial Hermann will leverage its expertise in trauma-focused healthcare, medical...
- The Defense Health Agency awarded Massachusetts General Hospital a $368,238 project grant under the Military Medical Research and Development program (CFDA 12.420) from September 1, 2023 through August 31, 2026. The grant will fund research to determine if microbiome-derived cell fragments in the brain accelerate transition from traumatic brain injury to Alzheimer's disease or related dementias. As a leading academic medical center, Massachusetts General Hospital will leverage its expertise in...
- This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
- The Defense Health Agency awarded a $1,316,000 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) on August 1, 2025 through the Military Medical Research and Development program (CFDA 12.420). The funding supports a 4-year research project titled "ADVANCING WRN AS A PROMISING THERAPEUTIC TARGET FOR MSI-H CANCERS" to conduct advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- Federal Grant Award Summary Health Research, Inc. received a $958,389 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026, through May 31, 2030. As the Roswell Park Division of Health Research, the organization will conduct advanced biomedical research at its Buffalo, New York location. Based on the awardee's established portfolio, the research is expected to advance healthcare solutions...
- The Department of the Army Medical Command awarded a $531,300 Project Grant to Hackensack University Medical Center to support research into the role of RUNX1 rearrangements in triple-negative breast cancer progression and immune evasion. The grant was awarded on September 15, 2022 under the Military Medical Research and Development program (CFDA 12.420), with a completion date of September 14, 2025. Through this funding, Hackensack University Medical Center will conduct research to...